Norepinephrine Infusion to prevent hypotension for cesarean delivery: a randomized controlled trial

A study for dose-dependent effects of intravenous norepinephrine infusion to prevent hypotension for cesarean delivery: a randomized controlled trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900022322

Enrollment

Unknown

Registered

2019-04-04

Start date

2019-04-01

Completion date

Unknown

Last updated

2019-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypotension

Interventions

Group N1:Norepinephrine infusion(0.025µg/kg/min)

Group N2:Norepinephrine infusion(0.05µg/kg/min)

Group N3:Norepinephrine infusion(0.075µg/kg/min)

Group N4:Norepinephrine infusion(0.10µg/kg/min)

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Parturients with a singleton pregnancy scheduled for elective cesarean delivery were enrolled into the study.

Exclusion criteria

Exclusion criteria: Patients were excluded if they had pre-existing or pregnancy-induced hypertension, diabetes mellitus, known cardiovascular or cerebrovascular disease, fetal abnormality, or contraindication to spinal anesthesia. The patients whose American Society of Anesthesiologists physical status (ASA >2), body mass index > 30 kg/m2, height 170 cm, gestational age < 36 weeks were also excluded from the study.

Design outcomes

Primary

Measure	Time frame
Blood pressure;	—

Countries

China

Contacts

Public ContactXinzhong Chen

chenxinz@zju.edu.cn+86 13575738058

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 28, 2026